Synthetic/JJ
glucocorticoids/NNS
that/WDT
dissociate/VBP
transactivation/NN
and/CC
AP-1/NN
transrepression/NN
exhibit/VBP
antiinflammatory/JJ
activity/NN
in/FW
vivo/FW
./.

Some/DT
of/IN
the/DT
most/RBS
potent/JJ
antiinflammatory/JJ
and/CC
immunosuppressive/JJ
agents/NNS
are/VBP
synthetic/JJ
glucocorticoids/NNS
./.
=====
However/RB
,/,
major/JJ
side/NN
effects/NNS
severely/RB
limit/VBP
their/PRP$
therapeutic/JJ
use/NN
./.
=====
The/DT
development/NN
of/IN
improved/JJ
glucocorticoid-based/JJ
drugs/NNS
will/MD
require/VB
the/DT
separation/NN
of/IN
beneficial/JJ
from/IN
deleterious/JJ
effects/NNS
./.
=====
One/CD
possibility/NN
toward/IN
this/DT
goal/NN
is/VBZ
to/TO
try/VB
to/TO
dissociate/VB
two/CD
main/JJ
activities/NNS
of/IN
glucocorticoids/NNS
,/,
i.e./FW
transactivation/NN
and/CC
transrepression/NN
./.
=====
Screening/NN
of/IN
a/DT
library/NN
of/IN
compounds/NNS
using/VBG
transactivation/NN
and/CC
AP-1/NN
transrepression/NN
models/NNS
in/IN
transiently/RB
transfected/VBN
cells/NNS
identified/VBD
dissociated/VBN
glucocorticoids/NNS
,/,
which/WDT
exert/VBP
strong/JJ
AP-1/NN
inhibition/NN
but/CC
little/JJ
or/CC
no/DT
transactivation/NN
./.
=====
Importantly/RB
,/,
despite/IN
high/JJ
ligand/NN
binding/NN
affinity/NN
,/,
the/DT
prototypic/JJ
dissociated/VBN
compound/NN
,/,
RU24858/NN
,/,
acted/VBD
as/IN
a/DT
weak/JJ
agonist/NN
and/CC
did/VBD
not/RB
efficiently/RB
antagonize/VB
dexamethasone-induced/JJ
transcription/NN
in/IN
transfected/VBN
cells/NNS
./.
=====
Similar/JJ
results/NNS
were/VBD
obtained/VBN
in/IN
hepatic/JJ
HTC/NN
cells/NNS
for/IN
the/DT
transactivation/NN
of/IN
the/DT
endogenous/JJ
tyrosine/NN
amino/NN
transferase/NN
gene/NN
(/(
TAT/NN
)/)
,/,
which/WDT
encodes/VBZ
one/CD
of/IN
the/DT
enzymes/NNS
involved/VBN
in/IN
the/DT
glucocorticoid-dependent/JJ
stimulation/NN
of/IN
neoglucogenesis/NN
./.
=====
To/TO
investigate/VB
whether/IN
dissociated/VBN
glucocorticoids/NNS
retained/VBD
the/DT
antiinflammatory/JJ
and/CC
immunosuppressive/JJ
potential/NN
of/IN
classic/JJ
glucocorticoids/NNS
,/,
several/JJ
in/FW
vitro/FW
and/CC
in/FW
vivo/FW
models/NNS
were/VBD
used/VBN
./.
=====
Indeed/RB
,/,
secretion/NN
of/IN
the/DT
proinflammatory/JJ
lymphokine/NN
interleukin-1beta/NN
was/VBD
severely/RB
inhibited/VBN
by/IN
dissociated/VBN
glucocorticoids/NNS
in/IN
human/JJ
monocytic/JJ
THP/NN
1/CD
cells/NNS
./.
=====
Moreover/RB
,/,
in/IN
two/CD
in/FW
vivo/FW
models/NNS
,/,
these/DT
compounds/NNS
exerted/VBD
an/DT
antiinflammatory/JJ
and/CC
immunosuppressive/JJ
activity/NN
as/IN
potent/JJ
as/IN
that/DT
of/IN
the/DT
classic/JJ
glucocorticoid/NN
prednisolone/NN
./.
=====
These/DT
results/NNS
may/MD
lead/VB
to/TO
an/DT
improvement/NN
of/IN
antiinflammatory/JJ
and/CC
immunosuppressive/JJ
therapies/NNS
and/CC
provide/VB
a/DT
novel/JJ
concept/NN
for/IN
drug/NN
discovery/NN
./.